Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Vladimir Tesar & Zdenka Hruskova. (2015) Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis – still of value for our patients?. Expert Opinion on Pharmacotherapy 16:11, pages 1683-1702.
Read now
Read now
Articles from other publishers (18)
Martin Windpessl, Philipp Gauckler, Emanuel Zitt, Karl Lhotta, Cihan Ay, Kathrin Eller, Balazs Odler, Irmgard Neumann, Michael Rudnicki, Andreas Kronbichler & Marcus D. Säemann. (2023) Allgemeine Empfehlungen für die Behandlung glomerulärer Erkrankungen – 2023General recommendations for the management of glomerular diseases—2023. Wiener klinische Wochenschrift 135:S5, pages 696-704.
Crossref
Crossref
Mohammad Amin Habibi, Samira Alesaeidi, Mohadeseh Zahedi, Samin Hakimi Rahmani, Seyed Mohammad Piri & Soheil Tavakolpour. (2022) The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review. Biology 11:12, pages 1767.
Crossref
Crossref
Jennifer Scott & Mark A. Little. 2022. Primer on Nephrology. Primer on Nephrology
467
488
.
Valérie Bénard, Cynthia Farhat, Melissa Zarandi‐Nowroozi, Madeleine Durand, Pierre Charles, Xavier Puéchal, Loic Guillevin, Christian Pagnoux & Jean‐Paul Makhzoum. (2021) Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis. ACR Open Rheumatology 3:7, pages 484-494.
Crossref
Crossref
Irmgard Neumann. (2020) Immunosuppressive and glucocorticoid therapy for the treatment of ANCA-asssociated vasculitis. Rheumatology 59:Supplement_3, pages iii60-iii67.
Crossref
Crossref
Clémence Thery-Casari, Romain Euvrard, Sabine Mainbourg, Stéphane Durupt, Quitterie Reynaud, Isabelle Durieu, Alexandre Belot, Hervé Lobbes, Natalia Cabrera & Jean-Christophe Lega. (2020) Severe infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides receiving rituximab: A meta-analysis. Autoimmunity Reviews 19:5, pages 102505.
Crossref
Crossref
Maurizio Salvadori & Aris Tsalouchos. (2018) Induction Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Renal Involvement: The Nephrologist’s Point of View. EMJ Nephrology, pages 85-95.
Crossref
Crossref
Maurizio Salvadori & Aris Tsalouchos. (2018) Antineutrophil cytoplasmic antibody associated vasculitides with renal involvement: Open challenges in the remission induction therapy. World Journal of Nephrology 7:3, pages 71-83.
Crossref
Crossref
Gizem Ayan, Sinem Nihal Esatoglu, Gulen Hatemi, Serdal Ugurlu, Emire Seyahi, Melike Melikoglu, Izzet Fresko, Huri Ozdogan, Sebahattin Yurdakul & Vedat Hamuryudan. (2018) Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies. Rheumatology International 38:4, pages 607-622.
Crossref
Crossref
Jonathan Oxley Oxland, Jason Ensor & Robert Freercks. (2018) Tuberculosis and pauci-immune crescentic glomerulonephritis. BMJ Case Reports, pages bcr-2017-221948.
Crossref
Crossref
Frank Hill, Jennifer Yonkof, Sri K. Chaitanya Arudra, Jean Thomas & Nezam Altorok. (2016) Successful Treatment of ANCA-Associated Vasculitis in the Setting of Common Variable Immunodeficiency Using Rituximab. American Journal of Therapeutics 23:5, pages e1239-e1245.
Crossref
Crossref
Duvuru Geetha, Zdenka Hruskova, Marten Segelmark, Jonathan Hogan, Matthew D. Morgan, Teresa Cavero, Per Eriksson, Philip Seo, Rebecca L. Manno, Jessica Dale, Lorraine Harper, Vladimir Tesar & David RW Jayne. (2015) Rituximab for treatment of severe renal disease in ANCA associated vasculitis. Journal of Nephrology 29:2, pages 195-201.
Crossref
Crossref
M. Haubitz. (2015) VaskulitidenVasculitis. Der Nephrologe 11:2, pages 124-133.
Crossref
Crossref
Andreas Kronbichler & David R. W. Jayne. (2015) Con: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab?. Nephrology Dialysis Transplantation 30:7, pages 1075-1081.
Crossref
Crossref
Duvuru Geetha, Cees Kallenberg, John H. Stone, Alan D. Salama, Gerald B. Appel, George Duna, Paul Brunetta & David Jayne. (2014) Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab. Journal of Nephrology 28:1, pages 17-27.
Crossref
Crossref
Gabriella Moroni & Claudio Ponticelli. (2014) Rapidly progressive crescentic glomerulonephritis: Early treatment is a must. Autoimmunity Reviews 13:7, pages 723-729.
Crossref
Crossref
F. Alberici & D. R. W. Jayne. (2013) Impact of rituximab trials on the treatment of ANCA-associated vasculitis. Nephrology Dialysis Transplantation 29:6, pages 1151-1159.
Crossref
Crossref
David Jayne. (2013) S2. Rituximab for ANCA-associated vasculitis: The UK experience. La Presse Médicale 42:4, pages 532-534.
Crossref
Crossref